Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Bayliss, Julianne, Yuen, Lilly, Rosenberg, Gillian, Wong, Darren, Littlejohn, Margaret, Jackson, Kathleen, Gaggar, Anuj, Kitrinos, Kathryn M, Subramanian, G Mani, Marcellin, Patrick, Buti, Maria, JansLanguage:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2015-309300
Date:
August, 2016
File:
PDF, 1.16 MB
english, 2016